Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
Provided By GlobeNewswire
Last update: Aug 14, 2024
WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the second quarter of 2024 and provided general business updates.
